Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 15, Issue 13, Pages 1863-1874Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/14656566.2014.937704
Keywords
COX inhibitor; migraine; NSAID
Categories
Funding
- Allergan
- Amgen
- Cumberland
- ElectroCore
- Merz
- OptiNose
- Troy Healthcare
Ask authors/readers for more resources
Introduction: Migraine is a common headache disorder that causes significant disability. COX inhibitors (also referred to as NSAIDs) are a frequently used treatment option. Areas covered: A PubMed search provided articles relating to migraine and COX inhibitors. This article reviews the mechanism of action of NSAIDs in migraine, specifically the inhibition of COX isoenzymes and prostaglandin synthesis. Their central and peripheral effects are reviewed. The evidence for the use of NSAIDs in acute, preventive and rescue therapy, as well as other special circumstances, is discussed. Expert opinion: We use NSAIDs as first-line acute treatment for migraine in both out-patient and in-patient settings, as well as for preventive treatment in menstrual migraine. We also employ NSAIDS as a bridge therapy. We feel more research is needed to develop a greater variation of dosage forms for current NSAIDs as well as more combination therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available